openPR Logo
Press release

Adrenal Insufficiency Market Size, Share & Forecast 2024-2031 | Most Leading likes - Acrotech Biopharma, Inc., Bausch Health, Canada Inc., AdvaCare Pharma, weefselpharma, Cipla Inc., Pfizer Inc

05-26-2025 04:03 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Adrenal Insufficiency Market

Adrenal Insufficiency Market

Global Adrenal Insufficiency Market reached US$ 367.7 million in 2022 and is expected to reach US$ 801.9 million by 2030, growing with a CAGR of 10.5% during the forecast period 2023-2030.

Adrenal Insufficiency Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/adrenal-insufficiency-market?ca

Adrenal insufficiency is a hormonal disorder where the adrenal glands do not produce enough cortisol and, in some cases, aldosterone. This can lead to symptoms such as fatigue, weight loss, low blood pressure, abdominal pain, and salt cravings. The condition may be primary (Addison's disease) or secondary due to pituitary dysfunction. Treatment typically involves lifelong hormone replacement therapy to manage symptoms and prevent adrenal crisis, a potentially life-threatening complication.

Major players in the Adrenal Insufficiency market

The prominent players in Adrenal Insufficiency market research report are: Acrotech Biopharma, Inc., Bausch Health, Canada Inc., AdvaCare Pharma, weefselpharma, Cipla Inc., Pfizer Inc, Wellona Pharma, Eugia US, Sandoz Inc., and Prevego Healthcare & Research Pvt Ltd.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Adrenal Insufficiency Market Key Development

→ In April 2022, Diurnal Group expanded its partnership with Er-Kim to handle the distribution and marketing of Alkindi and Efmody in Greece, Cyprus, and Malta.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/adrenal-insufficiency-market?ca

Adrenal Insufficiency Market Segments

By Type: Primary, Secondary, Tertiary

By Source: Congenital, Acquired

By Treatment: Glucocorticoid, Corticotropin, Others

By Route of Administration: Oral, Injectables, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The Adrenal Insufficiency industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Adrenal Insufficiency Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adrenal Insufficiency Market Size, Share & Forecast 2024-2031 | Most Leading likes - Acrotech Biopharma, Inc., Bausch Health, Canada Inc., AdvaCare Pharma, weefselpharma, Cipla Inc., Pfizer Inc here

News-ID: 4036380 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031, Driven by Supplements and Functional Foods Demand | DataM Intelligence
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading companies - Toyal America Inc, Hunan Ningxiang Jiweixin Metal Powder Co., Ltd., ECKA Granules
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad United States: Recent Industry
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billion by 2033 | Leading companies - Bayer AG, Haleon group of companies, Kenvue, Teva Pharmaceutical Industries Ltd
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market. Download your exclusive sample report today: (corporate email gets priority access):
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading companies - Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc.
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market. Download your exclusive sample report today: (corporate

All 5 Releases


More Releases for Adrenal

Adrenal Insufficiency Market to Reach USD 4.03 Billion by 2034
Pune, India - December 2025 - The global Adrenal Insufficiency Market, valued at USD 2.38 billion in 2024, is projected to reach USD 4.03 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of autoimmune disorders, enhanced diagnostic awareness, and advancements in glucocorticoid replacement therapies are fueling consistent market growth. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72005 Market Summary The Adrenal Insufficiency Market is
Adrenal crisis Market Insights Highlight Expanding Outlook Till 2034, DelveInsig …
DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Rising Cigarette Smoking Boost The Adrenal Cancer: Key Factor Driving The Growth …
The Adrenal Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Adrenal Cancer Diagnostics Market Size During the Forecast Period? Over the past few years, the market size for adrenal cancer diagnostics has been experiencing strong growth. It is projected to
Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2024-2032
The congenital adrenal hyperplasia treatment market size was valued at USD 422.9 million in 2023, driven by increasing government funding and assistance along with joint research. The market size is anticipated to grow at a CAGR of 8.10% during the forecast period of 2024-2032 to achieve a value of USD 852.42 million by 2032. Congenital Adrenal Hyperplasia Treatment: Introduction Congenital Adrenal Hyperplasia (CAH) treatment typically involves lifelong replacement of deficient hormones. For
Addison's Disease Testing: Diagnostic Approaches for Unveiling Adrenal Insuffici …
Addison Disease Testing Market 2023 Forecast: Unveiling Opportunities and Growth Addison Disease Testing Market research report helps to recognize the market challenges and opportunities. Global Addison Disease Testing Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including
Adrenal Insufficiency Market to Witness Growth by 2032, estimates DelveInsight
DelveInsight's "Adrenal Insufficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adrenal Insufficiency, historical and forecasted epidemiology as well as the Adrenal Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Adrenal Insufficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Adrenal Insufficiency market size